Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25392
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | See, Emily J | - |
dc.contributor.author | Ransley, David G | - |
dc.contributor.author | Polkinghorne, Kevan R | - |
dc.contributor.author | Toussaint, Nigel | - |
dc.contributor.author | Bailey, Michael | - |
dc.contributor.author | Johnson, David | - |
dc.contributor.author | Robbins, Raymond J | - |
dc.contributor.author | Bellomo, Rinaldo | - |
dc.date | 2020-11-16 | - |
dc.date.accessioned | 2020-11-25T04:54:40Z | - |
dc.date.available | 2020-11-25T04:54:40Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Internal medicine journal 2022; 52(1): 79-88 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/25392 | - |
dc.description.abstract | Survivors of acute kidney injury (AKI) are at increased risk of major adverse kidney events and international guidelines recommend individuals be evaluated 3 months following AKI. We describe practice patterns and predictors of post-AKI care in an Australian tertiary hospital. A retrospective analysis was undertaken of adults with AKI (defined by KDIGO criteria) admitted to a single centre between 2012 and 2016. The primary outcome was outpatient nephrology review at 3 months. Secondary outcomes included inpatient nephrology review, and outpatient serum creatinine and urinary protein measurements. Data were analysed using multivariable logistic and competing risk regression. Only 117 of 2111 patients with AKI (6%) were reviewed by a nephrologist at 3 months. Reviewed patients were more likely to have a higher discharge serum creatinine (OR 1.20 per 10 μmol/L increase, 95% CI 1.16-1.25) or a history of peripheral vascular disease (OR 1.77, 95% CI 1.00-3.14). They were less likely to be older (OR 0.66 per decade, 95% CI 0.57-0.76), or to have a history of liver (OR 0.47, 95% CI 0.26-0.87) or ischaemic heart disease (OR 0.50, 95% CI 0.27-0.94). AKI stage did not predict follow up. The median time from discharge to outpatient serum creatinine testing was 12 days (IQR 4-47) and proteinuria was measured in 538 patients (25%). A minority of admitted AKI patients receive recommended post-AKI care. Studies in other Australian institutions are required to confirm or refute these concerning findings. This article is protected by copyright. All rights reserved. | en |
dc.language.iso | eng | - |
dc.title | Practice patterns and predictors of outpatient care following acute kidney injury in an Australian healthcare setting. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Internal Medicine Journal | en |
dc.identifier.affiliation | Department for Continuing Education, University of Oxford, Oxford, United Kingdom | en |
dc.identifier.affiliation | Department of Medicine, Monash University, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Nephrology, Monash Health, Clayton, Australia | en |
dc.identifier.affiliation | Department of Epidemiology and Preventative Medicine, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia | en |
dc.identifier.affiliation | Data Analytics Research and Evaluation (DARE) Centre | en |
dc.identifier.affiliation | School of Medicine, University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia | en |
dc.identifier.affiliation | Intensive Care | en |
dc.identifier.affiliation | Department of Intensive Care, Royal Melbourne Hospital, Parkville, Australia | en |
dc.identifier.affiliation | Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Australia | en |
dc.identifier.affiliation | Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia | en |
dc.identifier.affiliation | Australasian Kidney Trials Network, Brisbane, Australia | en |
dc.identifier.affiliation | Translational Research Institute, Brisbane, Australia | en |
dc.identifier.doi | 10.1111/imj.15138 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0002-2853-5096 | en |
dc.identifier.pubmedid | 33197133 | - |
local.name.researcher | Bellomo, Rinaldo | - |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Clinical Analytics and Reporting | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.